They are talking about us! Allurion's newsroom

BBC
bloomberg
Daily Mail
Forbes
Tech Crunch
The Boston Globe
The Guardian
The wall street journal
Scientific American
Good Morning Britain
The New-York Times
UAE TODAY BloG

New Revolutionary Technology Can Be The Solution For UAE’s Dangerously High Obesity Numbers

UAE Today Blog - Available across clinics in the United Arab Emirates, the Elipse Program supports long-term weight loss through a revolutionary gastric balloon that creates a feeling of fullness by taking up space in the stomach, providing patients with the chance to take a break from dieting and that all too familiar feeling of hunger.

Trade Arabia

Gastric balloon helps lose weight without surgery

Trade Arabia - By combining a high-tech balloon solution with a full package of support to help its patients develop good lifestyle habits that can remain with them long after their balloon has gone, The Elipse Program results in more weight loss than diet or exercise alone.

Mashable Middle East

Gastric balloons that trick people into feeling full will protect Emiratis from obesity

Mashable Middle East - The entire program lasts for six months, which also comes with guidance from nutritionists that will integrate dietary changes in a person's lifestyle, to leave a lasting impact even after the treatment.

Gulf Daily News

Gastric balloon helps lose weight without surgery

Gulf Daily News - The Elipse Gastric Balloon by Allurion, the world's first and only weight loss device that requires no surgery, endoscopy, or anaesthesia, has been introduced in the UAE and is available across clinics in the country.

How can we help?

We’re here to answer any questions you may have.

This website describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration and is considered an investigational device. Our product is not available for sale in the United States. This website also has a Privacy Policy and Terms of Use that may reflect the laws and practices in other countries and jurisdictions, which may differ from those in the United States. We encourage you to review the Privacy Policy and Terms of Use.
APM003 REV 1 DCO0089

I understand